ProfileGDS4459 / ENSG00000234124
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 17% 7% 6% 8% 3% 3% 4% 3% 4% 5% 9% 4% 3% 4% 3% 4% 1% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.1917
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 22.747
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 31.966
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 42.888
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 51.793
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 62.073
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 71.834
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 81.613
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 91.714
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 101.945
GSM623474group B, liver allograft wedge biopsie placebo treatment 12.549
GSM623475group B, liver allograft wedge biopsie placebo treatment 21.714
GSM623476group B, liver allograft wedge biopsie placebo treatment 31.643
GSM623477group B, liver allograft wedge biopsie placebo treatment 42.544
GSM623478group B, liver allograft wedge biopsie placebo treatment 51.593
GSM623479group B, liver allograft wedge biopsie placebo treatment 62.514
GSM623480group B, liver allograft wedge biopsie placebo treatment 71.741